Search

Home > News & Events > Current News

Current News

Current SATVI news

5 October 2017 RESEARCH: Safety and Immunogenicity Immunogenicity of newborn MVA 85 A vaccination and selective delayed Bacille Calmette-Guerin for infants of HIV infected mothers: a Phase 2 Randomized Controlled Trial
Thursday, October 5, 2017 - 11:30

SATVI authors Dr Elisa Nemes, Prof Mark Hatherill, Associate Prof Tom Scriba, Dr Michele Tameris, Humphrey Mulenga and Danelle Van As have published a research paper titled: "Safety and Immunogenicity of newborn MVA 85 A vaccination and selective delayed Bacille Calmette-Guerin for infants of HIV infected mothers: a Phase 2 randomized controlled trial" appearing in the Infectious Disease Journal (Oxford).

3 October 2017 Research: Host blood signatures RNA predict the outcome of tuberculosis treatment
Tuesday, October 3, 2017 - 10:30

Associate Professor Tom Scriba has co-authored a article titled: "Host blood RNA predict the outcome of tuberculosis treatment" appearing in the Tuberculosis Journal.

21 September 2017 Vacancy Research Officer: Systems Immunology
Thursday, September 21, 2017 - 18:15

SATVI invites applications for the position of Research Officer: Systems Immunology at its Cape Town offices. CLOSED.

14 September 2017 Research: Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population
Friday, September 15, 2017 - 09:00

SATVI authors have published a research paper titled: "Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population" appearing in the PLoS ONE Journal.

8 September 2017 Research: A Functional Toll-Interacting Protein Variant associated with Bacillus Calmette-Guerin Specific Immune Response and Tuberculosis
Friday, September 8, 2017 - 08:00

Professor Mark Hatherill and Associate Professor Tom Scriba have co-authored a research paper titled "A Functional Toll-interacting Protein variant with Bacillus Calmette-Guerin specific immune responses and Tuberculosis" appearing in the American Journal of Respiratory and Critical Care Medicine.

7 September 2017 Research Published: Identifying specificity groups in T cell receptor repertoire
Thursday, September 7, 2017 - 17:15

Associate Professor Tom Scriba has co-authored a research paper titled "Identifying specificity groups in the T Cell receptor repertoire" appearing in the Nature Journal.

6 September 2017 Research Published: Protein kinase C-delta (PKCd), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice
Wednesday, September 6, 2017 - 20:15

SATVI authors Associate Professor Tom Scriba, Dr Stanley Mbandi Kimbung, Fatoumatta Darboe and Dr Adam Penn-Nicholson have co-authored a paper titled "Protein kinase C-delta (PKCd), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice" appearing in the Mucosol Immunology Journal.

6 September 2017 SATVI marks 3000th patient screened in CORTIS HR study.
Wednesday, September 6, 2017 - 19:00

SATVI recently marked the 3 000th patient who had been screened for participation in the Correlates of Risk of TB study (CORTIS-01).  

2 September 2017 Beadmaking to Beat TB
Wednesday, September 6, 2017 - 10:15

On Thursday 24 August 2017, the South African Tuberculosis Vaccine Initiative (SATVI) partnered with Ikamva Lethu, a women’s cooperative based in Worcester, in presenting a bead making workshop to learners at the Sinetemba Aftercare Centre in Zwelethemba, Worcester.

23 August 2017 Research Published: The CSF Immune Response in HIV-1‚ÄďAssociated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral Therapy
Wednesday, August 23, 2017 - 14:30

SATVI researcher Associate Professor Tom Scriba has co-authored a research paper titled: "The CSF Immune Response in HIV-1–Associated Cryptococcal Meningitis: Macrophage Activation, Correlates of Disease Severity, and Effect of Antiretroviral Therapy" appearing in the Journal of Acquired Immune Deficiency Syndrome.

15 August 2017 NEW VACANCY: Laboratory Technologist
Tuesday, August 15, 2017 - 14:30

South African Tuberculosis Vaccine Initiative (SATVI), located within Infectious Disease and Molecular Medicine (IDM) at the Faculty of Health Sciences invites applications from suitably qualified candidates for a 24-month contract position of Laboratory Technologist based in Worcester.                       CLOSED

14 August 2017 Research: Optimization and interpretation of serial QuantiFERON testing to measure acquisition of M. tuberculosis infection
Tuesday, August 15, 2017 - 13:15

SATVI authors have published research in which they find that the implementation of optimized procedures and a more rigorous QuantiFERON-TB conversion definition, an increase from IFNy<0.2 to >0.7 IU/mL, would allow more definitive detection of recent M.tb infection and potentially improve identification of those more likely to develop disease.

Pages